Featured News

SNBL USA Announces Appointment of Dr. Karla Thrall to Support Radiation Program

Everett, Wash., September 8, 2014 SNBL USA, the experts in primate research, is pleased to announce the appointment of Karla Thrall, PhD, DABT as Manager and Senior Study Director for SNBL USA’s Acute Radiation Syndrome (ARS) Program. Dr. Thrall will manage the coordination and scientific direction of SNBL’s ARS program. The scope of this program includes countermeasure evaluation resources from efficacy demonstration to nonclinical GLP studies under the FDA’s Animal Rule in both rodent and large animal models.


Business Collaboration SNBL & Sosei Group Corporation

Business Collaboration Letter of Intent Signed between SNBL and Sosei Group Corporation and Progress on Development of Novel Nasal Epinephrine Product Shin Nippon Biomedical Laboratories, Ltd. (“SNBL”; CEO: Ryoichi Nagata; Tokyo, Japan) announces in conjunction with Sosei Group Corporation (“Sosei”; CEO: Shinichi Tamura; Tokyo, Japan)


Dr. Tess Sergio Joins the SNBL USA Business Development Team

We are pleased to announce the recent appointment of Tess Sergio, DVM, as director of business development. Based in Singapore, Tess is responsible for providing scientific and business development support for clients in the Asia Pacific region.